Furosemide Use in Premature Infants and Appearance of Patent Ductus Arteriosus

Thomas P. Green, Theodore R. Thompson, Dana E Johnson, E. Lock James

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Furosemide is a known stimulant of the renal release of prostaglandin E2, a potent dilator of the ductus arteriosus. A possible relationship between furosemide use in infants with respiratory distress syndrome (RDS) and the incidence of patent ductus arteriosus (PDA) was investigated using two different retrospective analyses. The amount of furosemide administered prior to the day a murmur was heard in the infants with PDA was higher than the amount given to patients without PDA during the same period. In a historical analysis of patients treated for RDS in the years 1970 through 1979, furosemide use and fluid intake appeared to be independent factors contributing to the incidence of PDA. The proposed relationship between furosemide use and the occurrence of PDA in patients with RDS warrants further study.

Original languageEnglish (US)
Pages (from-to)239-243
Number of pages5
JournalAmerican Journal of Diseases of Children
Volume135
Issue number3
DOIs
StatePublished - Jan 1 1981

Fingerprint

Patent Ductus Arteriosus
Furosemide
Premature Infants
Newborn Respiratory Distress Syndrome
Ductus Arteriosus
Incidence
Dinoprostone
Kidney

Cite this

Furosemide Use in Premature Infants and Appearance of Patent Ductus Arteriosus. / Green, Thomas P.; Thompson, Theodore R.; Johnson, Dana E; James, E. Lock.

In: American Journal of Diseases of Children, Vol. 135, No. 3, 01.01.1981, p. 239-243.

Research output: Contribution to journalArticle

Green, Thomas P. ; Thompson, Theodore R. ; Johnson, Dana E ; James, E. Lock. / Furosemide Use in Premature Infants and Appearance of Patent Ductus Arteriosus. In: American Journal of Diseases of Children. 1981 ; Vol. 135, No. 3. pp. 239-243.
@article{ecb0e17e6e8148c0aa9c3d7df77bb355,
title = "Furosemide Use in Premature Infants and Appearance of Patent Ductus Arteriosus",
abstract = "Furosemide is a known stimulant of the renal release of prostaglandin E2, a potent dilator of the ductus arteriosus. A possible relationship between furosemide use in infants with respiratory distress syndrome (RDS) and the incidence of patent ductus arteriosus (PDA) was investigated using two different retrospective analyses. The amount of furosemide administered prior to the day a murmur was heard in the infants with PDA was higher than the amount given to patients without PDA during the same period. In a historical analysis of patients treated for RDS in the years 1970 through 1979, furosemide use and fluid intake appeared to be independent factors contributing to the incidence of PDA. The proposed relationship between furosemide use and the occurrence of PDA in patients with RDS warrants further study.",
author = "Green, {Thomas P.} and Thompson, {Theodore R.} and Johnson, {Dana E} and James, {E. Lock}",
year = "1981",
month = "1",
day = "1",
doi = "10.1001/archpedi.1981.02130270031011",
language = "English (US)",
volume = "135",
pages = "239--243",
journal = "JAMA Pediatrics",
issn = "2168-6203",
publisher = "American Medical Association",
number = "3",

}

TY - JOUR

T1 - Furosemide Use in Premature Infants and Appearance of Patent Ductus Arteriosus

AU - Green, Thomas P.

AU - Thompson, Theodore R.

AU - Johnson, Dana E

AU - James, E. Lock

PY - 1981/1/1

Y1 - 1981/1/1

N2 - Furosemide is a known stimulant of the renal release of prostaglandin E2, a potent dilator of the ductus arteriosus. A possible relationship between furosemide use in infants with respiratory distress syndrome (RDS) and the incidence of patent ductus arteriosus (PDA) was investigated using two different retrospective analyses. The amount of furosemide administered prior to the day a murmur was heard in the infants with PDA was higher than the amount given to patients without PDA during the same period. In a historical analysis of patients treated for RDS in the years 1970 through 1979, furosemide use and fluid intake appeared to be independent factors contributing to the incidence of PDA. The proposed relationship between furosemide use and the occurrence of PDA in patients with RDS warrants further study.

AB - Furosemide is a known stimulant of the renal release of prostaglandin E2, a potent dilator of the ductus arteriosus. A possible relationship between furosemide use in infants with respiratory distress syndrome (RDS) and the incidence of patent ductus arteriosus (PDA) was investigated using two different retrospective analyses. The amount of furosemide administered prior to the day a murmur was heard in the infants with PDA was higher than the amount given to patients without PDA during the same period. In a historical analysis of patients treated for RDS in the years 1970 through 1979, furosemide use and fluid intake appeared to be independent factors contributing to the incidence of PDA. The proposed relationship between furosemide use and the occurrence of PDA in patients with RDS warrants further study.

UR - http://www.scopus.com/inward/record.url?scp=0019476331&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019476331&partnerID=8YFLogxK

U2 - 10.1001/archpedi.1981.02130270031011

DO - 10.1001/archpedi.1981.02130270031011

M3 - Article

C2 - 7211779

AN - SCOPUS:0019476331

VL - 135

SP - 239

EP - 243

JO - JAMA Pediatrics

JF - JAMA Pediatrics

SN - 2168-6203

IS - 3

ER -